Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma × CP protocol × Tumor-Agnostic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Thoracic 1 Gynecologic 1

Conditions

Neoplasms, Unknown Primary 2 Carcinoma 1

Interventions

Carboplatin 9 Paclitaxel 8 Radiotherapy 7 pembrolizumab 6 Cisplatin 5 Axitinib 4 Pemetrexed 3 Nivolumab 3 trifluridine tipiracil drug combination 2 regorafenib 2 osimertinib 2 fludarabine 2 dacomitinib 2 Trastuzumab 2 Sunitinib 2 Radiotherapy, Intensity-Modulated 2 Interleukin-2 2 Gemcitabine 2 Docetaxel 2 Cyclophosphamide 2 Cetuximab 2 Bevacizumab 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 vatalanib 1 temsirolimus 1 sovateltide 1 selinexor 1 reolysin 1 relatlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00894569 2009-05-14

PACET-CUP

Heidelberg University

Phase 2 Unknown

Carcinoma, Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡